Articles by Jill Wechsler - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Jill Wechsler

Biotech Manufacturers Face Competition from "Similar" Follow-Ons

New legislation offers extended data exclusivity to innovators in exchange for a flexible approval process
Aug 1, 2007

The main testing and regulatory provisions of the FOB legislation reflect multiple trade-offs between the demands of innovators and generics firms.

ADVERTISEMENT

ADVERTISEMENT

Click here